Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q2 2024 Earnings Conference Call August 1, 2024 4:30 PM ET
Company Participants
Sharon Klahre - Head, IR
Michael Metzger - CEO
Steve Closter - Chief Commercial Officer
Keith Goldan - CFO
Neil Gallagher - President, Head of Research and Development
Conference Call Participants
Malcolm Kuno - JPMorgan
Kevin Sterling - Goldman Sachs
Ernie Rodriguez - TD Cowen
Brad Canino - Stifel
Michael Schmidt - Guggenheim
Ashiq Mubarack - Citi
Kalpit Patel - B. Riley
Justin Zelin - BTIG
Cameron Bozdog - Bank of America
Operator
Good day, everyone, and welcome to the Syndax Second Quarter 2024 Earnings Conference Call. Today's call is being recorded. [Operator Instructions]
At this time, I would like to turn the call over to Sharon Klahre, Head of Investor Relations at Syndax Pharmaceuticals.
Sharon Klahre
Thank you, operator. Welcome, and thank you all for joining us today for a review of Syndax's second quarter 2024 financial and operating results. I'm Sharon Klahre, and with me this afternoon to provide an update on the company's progress and discuss financial results are Michael Metzger, Chief Executive Officer; Dr. Neil Gallagher, President and Head of R&D; Steve Closter, Chief Commercial Officer; and Keith Goldan, Chief Financial Officer. Also joining us on the call today for the question-and-answer session are Dr. Peter Ordentlich, Chief Scientific Officer; and Dr. Anjali Ganguli, Chief Business Officer.
This call is accompanied by a slide deck that has been posted on the Investor page of the company's website. You can now turn to our forward-looking statements on Slide 2. Before we begin, I would like to remind you that any statements made during the call that are not historical are considered to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Actual results may differ materially from those indicated by these statements as a result of various important factors, including those discussed in the risk factors section in the company's most recent quarterly reports on Form 10-Q as well as other reports filed with the SEC. Any forward-looking statements made represent our views as of today, August 1st, 2024, only. A replay of this call will be available on the company's website, www.syndax.com, following its completion.
With that, I'm pleased to turn the call over to Michael Metzger, Chief Executive Officer of Syndax.
Michael Metzger
Thank you, Sharon. Good afternoon, everyone, and thank you for joining us today.